drugset / Trial / NCT01989936
Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan
RandomizedParallel-groupDouble-blindTreatment
Summary
To determine the tolerability and efficacy of eletriptan in patients who had discontinued oral sumatriptan due to lack of efficacy or intolerable adverse events (AEs) during previous clinical treatment (not a controlled trial).
Timeline
- Start
- 1999-01
- Primary completion
- 2000-09
- Completion
- 2000-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eletriptan | Small molecule | 40 mg | Oral |
| Subject | Eletriptan | Small molecule | 80 mg | Oral |